1-5 of 5
Federico Caligaris- Cappio, M.D.
Close
Sort by
Journal Articles

Interim Analysis of EFC6663, a Multicenter Phase 2 Study of Alvocidib (flavopiridol), Demonstrates Clinical Responses Among Patients with Fludarabine Refractory CLL

Mark C Lanasa, MD, PhD, Leslie Andritsos, MD, Jennifer R Brown, MD, PhD, Janice Gabrilove, M.D., Federico Caligaris-Cappio, M.D., Richard Larson, M.D., Thomas J. Kipps, MD, PhD, Veronique Leblond, M.D., Donald Milligan, MD, FRCP, FRCPath, Ann Janssens, M.D., Nyla A. Heerema, Ph.D., Stephan Stilgenbauer, M.D., John C. Byrd, MD, Michael R. Grever, M.D.
Journal: Blood
Blood (2010) 116 (21): 58.
https://doi.org/10.1182/blood.V116.21.58.58
Published: 2010
Journal Articles

Differential Functional Outcomes After Stimulation Via Innate Immunity Receptors In Chronic Lymphocytic Leukemia Subtypes Defined by the Molecular Features of the Immunoglobulin Receptor

Stavroula Ntoufa, Anna Vardi, Nikos Papakonstantinou, Achilles Anagnostopoulos, Vassiliki Aleporou-Marinou, Federico Caligaris-Cappio, M.D., Chrysoula Belessi, Paolo Ghia, Marta Muzio, Kostas Stamatopoulos
Journal: Blood
Blood (2010) 116 (21): 374.
https://doi.org/10.1182/blood.V116.21.374.374
Published: 2010
Journal Articles

Toll-Like Receptor Signaling Pathway In Chronic Lymphocytic Leukemia: Distinct Gene Expression Profiles of Potential Pathogenetic Significance In Specific Subsets of Patients

Eleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, Tasoula Touloumenidou, Nikolaos Laoutaris, Achilles Anagnostopoulos, Kleoniki Lamnisou, Federico Caligaris-Cappio, M.D., Kostas Stamatopoulos, Paolo Ghia, Marta Muzio, Chrysoula Belessi
Journal: Blood
Blood (2010) 116 (21): 44.
https://doi.org/10.1182/blood.V116.21.44.44
Published: 2010
Journal Articles

Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells.

Paolo Ghia, MD, PhD, Maria TS Bertilaccio, PhD, Cristina Scielzo, Giorgia Simonetti, Benedetta Apollonio, Claudia Fazi, Marta Muzio, PhD, Maurilio Ponzoni, MD, Federico Caligaris-Cappio, M.D.
Journal: Blood
Blood (2009) 114 (22): 360.
https://doi.org/10.1182/blood.V114.22.360.360
Published: 2009
Journal Articles

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Andres JM Ferreri, MD, Michele Reni, M.D., Marco Foppoli, M.D., Maurizio Martelli, M.D., Marina Siakantaris, M.D., Maurizio Frezzato, M.D., Maria Giuseppina Cabras, M.D., Alberto Fabbri, M.D., Gaetano Corazzelli, M.D., Fiorella Ilariucci, M.D., Giuseppe Rossi, M.D., Riccardo Soffietti, M.D., Caterina Stelitano, M.D., Daniele Vallisa, M.D., Francesco Zaja, M.D., Marta Gelemur, M.D., Gian Marco Aondio, M.D., Giuseppe Avvisati, M.D., Monica Balzarotti, MD, Alba Brandes, M.D., Maria Joao Costa, MD, Henry Gomez, M.D., Attilio Guarini, M.D., Graziella Pinotti, M.D., Luigi Rigacci, M.D., Catrina Uhlmann, M.D., Maria Angelopoulou, M.D., Maria Tirindelli, M.D., Virginia Naso, M.D., Alberto Franzin, M.D., Nicoletta Anzalone, M.D., Maurilio Ponzoni, M.D., Emanuele Zucca, M.D., Federico Caligaris- Cappio, M.D., Franco Cavalli, M.D.
Journal: Blood
Blood (2008) 112 (11): 580.
https://doi.org/10.1182/blood.V112.11.580.580
Published: 2008